Related Experiment Video
Updated: Aug 30, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Pharmacotherapy of Opioid Use Disorder-Update and Current Challenges
Savitha Racha1, Megan Buresh1, Michael Fingerhood1
1Department of Medicine, Division of Addiction Medicine, Johns Hopkins School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, East Tower, 2nd Floor, Baltimore, MD 21224, USA.
Abstract:
The incidence of opioid use disorder (OUD) and overdose deaths is rising yearly within the United States. Many cases are associated with illicitly manufactured fentanyl use. In addition to offering patients medications for OUD (methadone, buprenorphine, and naltrexone), the approach to this epidemic should involve increasing provider awareness and education about substance use disorders, expanding urine toxicology screens to test for fentanyl, and using low-threshold treatment approaches.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Therapy
Antianxiety Medications
Opioid Receptors: Overview

